Omada Health, Inc.

OMDA · NasdaqGS · Stock · Healthcare
$18.22
-0.44% today
Delayed price,

What Omada Health does

Omada Health, Inc., together with its subsidiary, Physera, Inc., provides a range of virtual care programs in the United States. The company offers cardiometabolic programs for prediabetes, diabetes, and hypertension; a physical therapy program to address musculoskeletal conditions; other support programs for members taking glucagon-like peptide-1 agonists in its cardiometabolic program; and weight management programs, as well as various behavioral health support programs. It also delivers virtual care. The company offers its programs for employers, health plans and systems, and pharmacy benefits managers through its direct sales force and channel partners. The company was incorporated in 2011 and is headquartered in South San Francisco, California.

Key facts

Sector
Healthcare
Industry
Health Information Services
Market cap
$1.12B
P/E (ttm)
75.9
Forward P/E
32.8
Dividend yield
0.00%
Beta
—
Profit margin
1.4%
Employees
946
Headquarters
South San Francisco, CA, United States
Exchange
NasdaqGS

Performance

1 Month
-10.8%
3 Months
-23.1%
6 Months
+28.9%
1 Year
-26.9%
5 Years
+4.0%
$10.2852-week range$26.92
Biggest setback — last 12 months
-56.3%
20 Oct 2025 → 9 Feb 2026
Fell from $25.87 to $11.31 — its sharpest sustained decline this year.
Biggest run-up — last 12 months
+112.6%
9 Feb 2026 → 10 Aug 2026
Ran from $11.31 to $24.04 — its strongest sustained advance this year.

Price outlook — trend & volatility model

● Trend: Above long-term trend
Price sits above its 200-day average, but the shorter-term averages are not cleanly aligned above/below it.
HorizonBear case (−1σ)Base caseBull case (+1σ)
1 Month$15.06 (-17.3%)$18.22$22.04 (+20.9%)
3 Months$13.11 (-28.1%)$18.22$25.33 (+39.0%)
6 Months$11.43 (-37.2%)$18.22$29.03 (+59.3%)
12 Months$9.43 (-48.3%)$18.22$35.21 (+93.3%)
Statistical, not machine-learning: a random-walk (no assumed drift) volatility model built from this ticker's own realized price history, plus a purely descriptive moving-average trend read. Illustrative only — not a price target and not financial advice. The bear and bull cases sit one standard deviation (1σ) below and above today's price, a range that covers about 68% of the outcomes the model treats as plausible, not a 68% chance of either case. Annualized volatility used: 65.9%, blended from this ticker's own 3-month and 1-year realized price history. Base case is deliberately flat — this quantifies a possible range, not a directional prediction. See the full model, including wider (≈95%) bands →

Comparable companies

Recent headlines

Recent insider activity

Acquired 694 shares — ROOT JONATHAN D, Director · 2026-10-07
Acquired 549 shares — Klapstein Julie D, Director · 2026-10-07
Acquired 751 shares — FETTER TREVOR, Director · 2026-10-07
Acquired 1,214 shares — HILLEMAN JERYL L, Director · 2026-10-07
Sold 34,516 shares at $20.90 — Duffy Sean P., Chief Executive Officer · 2026-10-05
Source: SEC Form 4 filings. An "acquired" entry with no price is typically a stock award or option exercise rather than an open-market purchase. Search all insider trades →

Learn the basics

Prices and company data are delayed reference figures from public sources (Yahoo Finance, SEC EDGAR) and may be inaccurate or out of date. This page is informational only — it is not investment advice or a recommendation to buy or sell any security. Past performance does not indicate future results.